FDA Approved: MERCAPTOPURINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for mercaptopurine from Mylan Pharmaceuticals Inc., authorizing a generic version under an approved ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Mercaptopurine (Mercaptopurine)

Snippet

SUPPL AP for MERCAPTOPURINE (MERCAPTOPURINE)